November 16, 2017 5:30pm

A trifecta, the IBB (+1.49%), XBI (+1.79%) and XLV (+1.04%) are up

Right again, having stated, “it is time to sweep the floor of those “bottom” shavings and buy in on some oversold as I don’t see many overbought!”

 

While the hyped, Capricor (CAPR -$0.15) craters again, the collapsed Biostage (BSTG -$0.00) waits to see if the SEC takes the field and Applied Genetic Technologies (AGTC - $0.00) goes nowhere and does nothing as usual for their forgotten shareholders?

 

Daily pre-open indications: 3 hits and 1 miss (by pennies)

 

How right does one have to be? You could and should be reading this review of the day’s share pricing activity?

Is the truth so hard to fathom – that’s why my readership has grown exponentially!


Members only. Please login.